429 related articles for article (PubMed ID: 10378888)
1. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.
Young JC; Lin K; Hansteen G; Travis M; Murray LJ; Jaing L; Scollay R; Hill BL
Exp Hematol; 1999 Jun; 27(6):994-1003. PubMed ID: 10378888
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+ Thy-1+ cells into rapid division.
Murray LJ; Young JC; Osborne LJ; Luens KM; Scollay R; Hill BL
Exp Hematol; 1999 Jun; 27(6):1019-28. PubMed ID: 10378891
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone.
Luens KM; Travis MA; Chen BP; Hill BL; Scollay R; Murray LJ
Blood; 1998 Feb; 91(4):1206-15. PubMed ID: 9454750
[TBL] [Abstract][Full Text] [Related]
4. Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities.
Uchida N; Combs J; Chen S; Zanjani E; Hoffman R; Tsukamoto A
Blood; 1996 Aug; 88(4):1297-305. PubMed ID: 8695847
[TBL] [Abstract][Full Text] [Related]
5. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.
Kusadasi N; van Soest PL; Mayen AE; Koevoet JL; Ploemacher RE
Leukemia; 2000 Nov; 14(11):1944-53. PubMed ID: 11069030
[TBL] [Abstract][Full Text] [Related]
6. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood.
Tanavde VM; Malehorn MT; Lumkul R; Gao Z; Wingard J; Garrett ES; Civin CI
Exp Hematol; 2002 Jul; 30(7):816-23. PubMed ID: 12135681
[TBL] [Abstract][Full Text] [Related]
7. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.
Danet GH; Lee HW; Luongo JL; Simon MC; Bonnet DA
Exp Hematol; 2001 Dec; 29(12):1465-73. PubMed ID: 11750106
[TBL] [Abstract][Full Text] [Related]
8. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood.
Murray L; Chen B; Galy A; Chen S; Tushinski R; Uchida N; Negrin R; Tricot G; Jagannath S; Vesole D
Blood; 1995 Jan; 85(2):368-78. PubMed ID: 7529060
[TBL] [Abstract][Full Text] [Related]
9. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice.
Herrera C; Sánchez J; Torres A; Bellido C; Rueda A; Alvarez MA
Br J Haematol; 2001 Sep; 114(4):920-30. PubMed ID: 11564087
[TBL] [Abstract][Full Text] [Related]
10. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
11. Role of different medium and growth factors on placental blood stem cell expansion: an in vitro and in vivo study.
Berger M; Fagioli F; Piacibello W; Sanavio F; Mareschi K; Biasin E; Bruno S; Gammaitoni L; Gunetti M; Nesi F; Madon E; Aglietta M
Bone Marrow Transplant; 2002 Mar; 29(5):443-8. PubMed ID: 11919735
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
[TBL] [Abstract][Full Text] [Related]
13. Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
Van den Berg D; Wessman M; Murray L; Tong J; Chen B; Chen S; Simonetti D; King J; Yamasaki G; DiGiusto R; Gearing D; Reading C
Blood; 1996 May; 87(10):4348-57. PubMed ID: 8639795
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand.
Feugier P; Jo DY; Shieh JH; MacKenzie KL; Rafii S; Crystal RG; Moore MA
J Hematother Stem Cell Res; 2002 Feb; 11(1):127-38. PubMed ID: 11847009
[TBL] [Abstract][Full Text] [Related]
15. CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells.
Murray LJ; Bruno E; Uchida N; Hoffman R; Nayar R; Yeo EL; Schuh AC; Sutherland DR
Exp Hematol; 1999 Aug; 27(8):1282-94. PubMed ID: 10428505
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo culture of cord blood CD34+ cells expands progenitor cell numbers, preserves engraftment capacity in nonobese diabetic/severe combined immunodeficient mice, and enhances retroviral transduction efficiency.
Novelli EM; Cheng L; Yang Y; Leung W; Ramírez M; Tanavde V; Enger C; Civin CI
Hum Gene Ther; 1999 Dec; 10(18):2927-40. PubMed ID: 10609654
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.
Chen BP; Fraser C; Reading C; Murray L; Uchida N; Galy A; Sasaki D; Tricot G; Jagannath S; Barlogie B
Leukemia; 1995 Oct; 9 Suppl 1():S17-25. PubMed ID: 7475307
[TBL] [Abstract][Full Text] [Related]
18. Investigation into an engraftment defect induced by culturing primitive hematopoietic cells with cytokines.
Young JC; Lin K; Travis M; Hansteen G; Abitorabi A; Sirenko O; Murray L; Hill B
Cytotherapy; 2001; 3(4):307-20. PubMed ID: 12171719
[TBL] [Abstract][Full Text] [Related]
19. Stromal support augments extended long-term ex vivo expansion of hemopoietic progenitor cells.
Kusadasi N; Koevoet JL; van Soest PL; Ploemacher RE
Leukemia; 2001 Sep; 15(9):1347-58. PubMed ID: 11516095
[TBL] [Abstract][Full Text] [Related]
20. Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture.
Young JC; Varma A; DiGiusto D; Backer MP
Blood; 1996 Jan; 87(2):545-56. PubMed ID: 8555476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]